Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability.

Abstract

Technetium-99m-tetrofosmin single-photon emission computed tomography at rest is practical for routine assessment of viability in patients with ischemic cardiomyopathy. However, underestimation of viability may occur compared with 18F-fluorodeoxyglucose single-photon emission computed tomography, especially in the inferoposterior and septal regions.

• Authors: Arend F L Schinkel, Jeroen J Bax, Elena Biagini, Abdou Elhendy, Ron T van Domburg, Roelf Valkema, Vittoria Rizzello, Olaf Schouten, Maarten Simoons, Don Poldermans
• Journal: The American journal of cardiology (Am J Cardiol) Vol. 95 Issue 10 Pg. 1223-5 (May 15 2005) ISSN: 0002-9149 [Print] United States
• PMID: 15877995 (Publication Type: Comparative Study, Evaluation Study, Journal Article)

Chemical References

• Organophosphorus Compounds
• Organotechnetium Compounds
• Radiopharmaceuticals
• Fluorodeoxyglucose F18
• technetium tc-99m tetrofosmin

Topics

• Coronary Artery Disease (diagnostic imaging, pathology)
• Female
• Fluorodeoxyglucose F18
• Humans
• Male
• Middle Aged
• Organophosphorus Compounds
• Organotechnetium Compounds
• Predictive Value of Tests
• Radiopharmaceuticals
• Tomography, Emission-Computed, Single-Photon (methods)
• Ventricular Dysfunction, Left (diagnostic imaging, pathology)